Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
Clinical trial NCT07660835 · RECRUITING
Trial details
- NCT number
- NCT07660835
- Sponsor
- Galderma R&D
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-13
- Primary completion
- 2028-07-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.